High-efficacy therapy found to cut disability progression in pediatric MS study
Treatment of pediatric-onset relapsing-remitting multiple sclerosis with high-efficacy therapy reduces the risk for transition across disability states, according to a study published in the May issue of The Lancet Child ...
Apr 15, 2024
0
0